对转移和直接入院的抗凝血相关的脑内出血患者的护理及时性
Regina Royan1,2,3, Jeffrey L Saver4, Nicole Solomon5
1Department of Emergency Medicine University of Michigan Ann Arbor MI USA.
Journal of the American Heart Association
|February 18, 2026
概括
与抗凝剂相关的脑内出血的转移患者经历了较长的抗凝剂逆转时间,但与直接入院患者相比,中风的严重性较小,住院死亡率较低.
科学领域:
- 神经学 神经学
- 心脏病学 心脏病学
- 公共卫生 公共卫生
背景情况:
- 与抗凝剂相关的脑内出血 (AC-ICH) 通常需要将患者转移到专门设施.
- 了解转移和直接入院之间的护理差异对于质量改善至关重要.
研究的目的:
- 为了比较护理的及时性和转移与AC-ICH患者直接入院的结果.
- 确定管理AC-ICH的潜在质量改进机会.
主要方法:
- 一项横截面研究分析了美国心脏协会获得指南-中风注册表 (2015-2021) 的数据.
- 包括在24小时内出现AC-ICH的患者,这些患者接受了抗凝剂逆转.
- 评估的结果包括功能状态,死亡率和逗留时间.
主要成果:
- 近一半 (48.6%) 的AC-ICH患者是转移患者.
- 转移患者的症状发作到逆转时间明显较长 (512分钟与273分钟相比).
- 转移患者出现了较轻的中风严重程度,但在医院死亡的几率较低 (aOR 0.78).
结论:
- 转移患有AC-ICH的患者会导致抗凝剂逆转的延迟.
- 尽管有延迟,转移患者的中风不那么严重,医院内死亡率降低.
- 在功能性结果或排放目的地方面没有观察到显著差异.
相关概念视频
Venous Thrombosis III: Interprofessional Care
388
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
388
Venous Thrombosis IV: Nursing Management
278
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
278
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.0K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.0K
Acute Coronary Syndrome IV: Interprofessional Care
313
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
313
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
511
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
511
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.5K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.5K


